In Situ Self‐Assembly Supramolecular Antagonist Reinforces Radiotherapy by Inhibiting Tumor Apoptosis Evasion
暂无分享,去创建一个
Fan Huang | Jianfeng Liu | Yumin Zhang | Wenxue Zhang | Jinjian Liu | Xiaoxue Hou | Lijun Yang | Dianyu Wang | Linzhu Su | Shiyu Peng | Paiyun Li | Qian Wang
[1] Chunhua Ren,et al. In Situ Transformable Supramolecular Nanomedicine Targeted Activating Hippo Pathway for Triple-Negative Breast Cancer Growth and Metastasis Inhibition. , 2022, ACS nano.
[2] Cuihong Yang,et al. Supramolecular Nitric Oxide Depot for Hypoxic Tumor Vessel Normalization and Radiosensitization , 2022, Advanced materials.
[3] Chun Wang,et al. Arginine‐Rich Polymers with Pore‐Forming Capability Enable Efficient Intracellular Delivery via Direct Translocation Across Cell Membrane , 2022, Advanced healthcare materials.
[4] C. Alonso-Moreno,et al. Clinical considerations for the design of PROTACs in cancer , 2022, Molecular cancer.
[5] Fan Huang,et al. Supramolecular Radiosensitizer Based on Hypoxia‐Responsive Macrocycle , 2022, Advanced science.
[6] Fan Huang,et al. Stapled Liposomes Enhance Cross‐Priming of Radio‐Immunotherapy , 2021, Advanced materials.
[7] Zhongyan Wang,et al. Adaptable peptide-based therapeutics modulating tumor microenvironment for combinatorial radio-immunotherapy. , 2021, Journal of controlled release : official journal of the Controlled Release Society.
[8] Zhimou Yang,et al. Selective Degradation of PD‐L1 in Cancer Cells by Enzyme‐Instructed Self‐Assembly , 2021, Advanced Functional Materials.
[9] Linqi Shi,et al. Supramolecular Antagonists Promote Mitochondrial Dysfunction. , 2021, Nano letters.
[10] Hao Wang,et al. Regulating Twisted Skeleton to Construct Organ-Specific Perylene for Intensive Cancer Chemotherapy. , 2021, Angewandte Chemie.
[11] Qianqian Wang,et al. In Situ Supramolecular Self‐Assembly of Pt(IV) Prodrug to Conquer Cisplatin Resistance , 2021, Advanced Functional Materials.
[12] Xiaodong Zhang,et al. Dual Gate-Controlled Therapeutics for Overcoming Bacterium-Induced Drug Resistance and Potentiating Cancer Immunotherapy. , 2021, Angewandte Chemie.
[13] D. Ding,et al. Supramolecular Self‐Assembly‐Facilitated Aggregation of Tumor‐Specific Transmembrane Receptors for Signaling Activation and Converting Immunologically Cold to Hot Tumors , 2021, Advanced materials.
[14] Fang Hu,et al. Bioorthogonal Coordination Polymer Nanoparticles with Aggregation‐Induced Emission for Deep Tumor‐Penetrating Radio‐ and Radiodynamic Therapy , 2021, Advanced materials.
[15] Paul C. Wang,et al. Proton-driven transformable nanovaccine for cancer immunotherapy , 2020, Nature Nanotechnology.
[16] P. Laktionov,et al. miRNAs and radiotherapy response in prostate cancer , 2020, Andrology.
[17] Kwangmeyung Kim,et al. Cancer-specific drug-drug nanoparticles of pro-apoptotic and cathepsin B-cleavable peptide-conjugated doxorubicin for drug-resistant cancer therapy. , 2020, Biomaterials.
[18] G. Stark,et al. Inflammation mobilizes copper metabolism to promote colon tumorigenesis via an IL-17-STEAP4-XIAP axis , 2020, Nature Communications.
[19] R. Hicks,et al. Peptide Receptor Radiotherapy: Current Approaches and Future Directions , 2019, Current Treatment Options in Oncology.
[20] Xing-jie Liang,et al. Enhanced Radiosensitization by Gold Nanoparticles with Acid‐Triggered Aggregation in Cancer Radiotherapy , 2019, Advanced science.
[21] Xuesi Chen,et al. Tailoring Platinum(IV) Amphiphiles for Self-Targeting All-in-One Assemblies as Precise Multimodal Theranostic Nanomedicine. , 2018, ACS nano.
[22] Merve Cakir,et al. Dysregulation of mitochondrial dynamics proteins are a targetable feature of human tumors , 2018, Nature Communications.
[23] Dan Ding,et al. Supramolecular Nanofibers of Curcumin for Highly Amplified Radiosensitization of Colorectal Cancers to Ionizing Radiation , 2018, Advanced Functional Materials.
[24] C. Punt,et al. From tumour heterogeneity to advances in precision treatment of colorectal cancer , 2017, Nature Reviews Clinical Oncology.
[25] Richard A. Adams,et al. Clinical development of new drug–radiotherapy combinations , 2016, Nature Reviews Clinical Oncology.
[26] Nuria Oliva,et al. Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model. , 2016, Nature materials.
[27] Jie Zhou,et al. Enzyme-Instructed Self-Assembly of Small d-Peptides as a Multiple-Step Process for Selectively Killing Cancer Cells , 2016, Journal of the American Chemical Society.
[28] W. McBride,et al. Opportunities and challenges of radiotherapy for treating cancer , 2015, Nature Reviews Clinical Oncology.
[29] Zijian Guo,et al. H2O2-activatable and O2-evolving nanoparticles for highly efficient and selective photodynamic therapy against hypoxic tumor cells. , 2015, Journal of the American Chemical Society.
[30] A. Ashworth,et al. The DNA damage response and cancer therapy , 2012, Nature.
[31] Fiona A. Stewart,et al. Strategies to improve radiotherapy with targeted drugs , 2011, Nature Reviews Cancer.
[32] F. Sharom,et al. ABC efflux pump-based resistance to chemotherapy drugs. , 2009, Chemical reviews.
[33] Su Qiu,et al. Design of small-molecule peptidic and nonpeptidic Smac mimetics. , 2008, Accounts of chemical research.
[34] J. Brown,et al. Exploiting tumour hypoxia in cancer treatment , 2004, Nature Reviews Cancer.
[35] Stephen F. Betz,et al. Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain , 2000, Nature.
[36] Te Vuong,et al. Past, present, and future of radiotherapy for the benefit of patients , 2013, Nature Reviews Clinical Oncology.
[37] Michael Weller,et al. Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo , 2002, Nature Medicine.